alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,476–7,500 of 7,816 matching trials · page 300 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
NCT00607308
PF-04360365; PF-04360365; PF-04360365; PF-04360365; Placebo; PF-04360365
Runs in: Japan · 9 sites 		PHASE1
other		 COMPLETED 20 Pfizer
INDUSTRY		 2010-12-07
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
NCT00253123
risperidone 		PHASE3
other		 COMPLETED 626 Janssen, LP
INDUSTRY		 2010-12-03
Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease
NCT00800709
Memantine
Runs in: China · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 26 Shanghai Mental Health Center
OTHER		 2010-12-03
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia
NCT00866645
Intramuscular Haloperidol; Intramuscular Levosulpiride
Runs in: China · 5 sites 		PHASE2|PHASE3
other		 COMPLETED 240 Shanghai Mental Health Center
OTHER		 2010-12-03
Comparative Bioavailability in Healthy Elderly Volunteers
NCT01253122
TRx0037 		PHASE1
other		 COMPLETED 24 TauRx Therapeutics Ltd
INDUSTRY		 2010-12-03
A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
NCT00249158
Risperidone 		PHASE3
other		 COMPLETED 344 Janssen-Cilag Pty Ltd
INDUSTRY		 2010-11-19
Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers
NCT00777361
AZD3480; AZD3480
Runs in: United Kingdom · 1 site 		PHASE1
other		 TERMINATED 9 AstraZeneca
INDUSTRY		 2010-11-18
Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)
NCT00637442
Reminyl retard
Runs in: Germany · 1 site 		NA
other		 UNKNOWN 30 University Hospital, Bonn
OTHER		 2010-11-09
Alzheimer's Disease Prevention Trial
NCT00000176
Estrogen; Estrogen and Progesterone
Runs in: United States · 22 sites 		PHASE3
other		 COMPLETED — National Institute on Aging (NIA)
NIH		 2010-11-05
A Safety and Tolerability Study of ABT-126 in Elderly
NCT00867399
ABT-126
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 30 Abbott
INDUSTRY		 2010-11-02
A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease
NCT00736775
anti-Abeta; placebo 		PHASE1
other		 COMPLETED 56 Genentech, Inc.
INDUSTRY		 2010-10-27
Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease
NCT00495417
AFFITOPE AD01; AFFITOPE AD01 adjuvanted
Runs in: Austria · 1 site 		PHASE1
other		 COMPLETED 24 Affiris AG
INDUSTRY		 2010-10-19
Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease
NCT00633841
AFFITOPE AD02
Runs in: Austria · 1 site 		PHASE1
other		 COMPLETED 24 Affiris AG
INDUSTRY		 2010-10-19
Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02
NCT01093664
AFFITOPE AD02
Runs in: Austria · 1 site 		PHASE1
other		 COMPLETED 20 Affiris AG
INDUSTRY		 2010-10-19
Preventing Aggressive Behavior in Demented Patients
NCT00622128
Preventing Aggressive Behavior in Demented Patients
Runs in: United States · 1 site 		PHASE3
other		 COMPLETED 10 US Department of Veterans Affairs
OTHER_GOV		 2010-10-18
Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes
NCT01220622
Nimodipine; Placebo
Runs in: China · 1 site 		PHASE4
other		 UNKNOWN 656 Ministry of Science and Technology of the People´s Republic of China
OTHER_GOV		 2010-10-14
Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects
NCT00605046
SPECT scan
Runs in: United States · 2 sites 		PHASE1
other		 TERMINATED 1 Institute for Neurodegenerative Disorders
OTHER		 2010-10-06
Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
NCT00605059
[123I]AV94
Runs in: United States · 2 sites 		PHASE1
other		 TERMINATED 3 Institute for Neurodegenerative Disorders
OTHER		 2010-10-06
Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513
NCT01000870
MNI-513-01
Runs in: United States · 1 site 		EARLY_PHASE1
other		 TERMINATED 6 Institute for Neurodegenerative Disorders
OTHER		 2010-10-06
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
NCT00322153
memantine ER; Placebo
Runs in: Argentina; Chile; Mexico; United States · 83 sites 		PHASE3
symptomatic-cholinergic		 COMPLETED 677 Forest Laboratories
INDUSTRY		 2010-09-16
Donepezil Treatment of Psychotic Symptoms in Dementia Patients
NCT00190021
donepezil
Runs in: Israel · 1 site 		PHASE3
symptomatic-cholinergic		 UNKNOWN 80 Beersheva Mental Health Center
OTHER_GOV		 2010-09-08
Project TAP: Tailored Activities Project
NCT00259467
Home-Based Behavorial Intervention
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 60 Thomas Jefferson University
OTHER		 2010-08-25
Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered
NCT00966966
SAM-531 and gemfibrozil
Runs in: Netherlands · 1 site 		PHASE1
other		 COMPLETED 17 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2010-08-20
Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone
NCT00392912
AndroGel (Solvay Pharmaceuticals)
Runs in: United States · 1 site 		NA
other		 COMPLETED 10 Michael E. DeBakey VA Medical Center
OTHER_GOV		 2010-08-19
Lighthouse Project on Dementia, Ulm, Germany
NCT00693888
advice (e.g. medical and social aspects, care, support at home, res...
Runs in: Germany · 1 site 		NA
other		 UNKNOWN 200 University of Ulm
OTHER		 2010-08-17

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →